Saturday, 20 April 2024
Kalvista Pharmaceuticals Inc.
NASDAQ : KALV
4.560 14 Oct 22 00:00 | Change: 0.03 | Open: 4.540 | High: 4.730 | Ask: 0.000 | Volume: 520,200 |
Change(%): 0.66 | Prev: 4.530 | Low: 4.500 | Bid: 0.000 | Avg vol: 0 |
05:07 | 17/3/18
Market Exclusive
On March 16, 2018, KalVista Pharmaceuticals, Inc. (the “Company”) reported its financial results for the three months ended January 31, 2018.
more»
00:26 | 17/3/18
Business Wire
KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need.
more»
01:22 | 6/3/18
Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will ...
more»
06:03 | 15/2/18
Frisco Fastball
About 10,176 shares traded. KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) has declined 43.18% since February 14, 2017 and is downtrending.
more»
13:33 | 5/2/18
Aiken Advocate
Currently, Kalvista Pharmaceuticals Inc (KALV) has a 14-day ATR of 0.71. The Average True Range is an investor tool used to measure stock volatility.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |